Skip to content
Loading…
Two German companies, Mahle GmbH and Schott Pharma AG, are exploring initial public offerings of their Indian businesses that could raise as much as $400 million each, according to people familiar with the matter, as multinational firms seek to tap the premium valuations…
To respect copyright, we link to the source rather than republishing the full text. Read the complete article on Bloomberg.